医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

三个遗传性血小板无力症家系临床表型和基因表型诊断的研究

Analysis of phenotype and genotype in three Chinese pedigrees with glanzmann thrombasthenia

摘要目的 对3个遗传性血小板无力症(glanzmann thrombasthenia,GT)家系进行血小板膜糖蛋白Ⅱ b、Ⅲa(GPⅡb/GPⅢa)基因突变的检测.方法 应用PCR对先证者GPⅡb/GPⅢa基因所有外显子及其侧翼序列进行扩增;PCR产物纯化后直接测序,检测其突变基因.突变位点经直接测序证实排除基因多态性.结果 3个家系的先证者PLT均正常,血小板形态分散,出血时间(BT)延长,凝血象正常,对二磷酸腺苷(ADP)、凝血酶、.肾上腺素、胶原、花生四烯酸等多种诱聚剂反应低下,而对瑞斯托霉素反应基本正常;家系1和家系2先证者的血小板膜表面CD41(GPⅡ b)/CD61(GPⅢa)的含量极度降低,分别为0.16%/1.8%、0.9%/3.7%,家系3先证者的血小板膜表面GP Ⅱ b阳性血小板为10.1%,GPⅢa阳性血小板为12.8%.免疫印迹法几乎检测不到家系1和家系3先证者的αⅡb蛋白,家系2先证者的αⅡb蛋白含量明显降低.家系1先证者在GP Ⅱ b基因存在T2255G和C2671T复合杂合突变,家系2先证者在GPⅡb基因存在A2334C纯合突变,家系3先证者在GP Ⅱ b基因存在C1750T和69-79del复合杂合突变.结论 T2255G和C2671T复合杂合突变是导致家系1先证者发生GT的原因,A2334C纯合突变是导致家系2先证者发生GT的原因,C1750T和69-79 del复合杂合突变是导致家系3先证者发生GT的原因.

更多

abstractsObjective To identify the gene mutations of platelet membrane glycoprotein Ⅱ b,Ⅲa(GPⅡb/Ⅲa)in three Chinese pedigrees with Glanzmann thrombastIlenia.Methods All exons and exonintron boundaries of GP Ⅱ b/Ⅲ a gene were amplified by PCR analysis followed by DNA sequencing.DNA sequencing was used to exclude gene polymorphisms.Results The probands in the three pedigrees had a normal platelet count,coagulation profiles,scattered platelets on the blood film,a prolonged cutaneous bleeding time,and impaired or minimal ex vivo platelet aggregation in response to ADP,thrombin,collagen,adrenaline and arachidonic acid,but normal platelet aggregation in response to ristoeetin.Both FACS and Western blotting demonstrated trace content of αⅡb in the platelets from proband 1 and proband 3,who were classified as type Ⅰ GT,and a small amount of αⅡb in the platelets from proband 2,who was classified as type Ⅱ GT.Compound heterozygous mutations,T2255G(Leu721Arg)and C2671T(Gln860Stop)were identified in proband 1.The proband 2 had homozygous A2334C(Gln747Pro)missense mutation.Nonsense mutations C1750T (Arg584Stop)and 69-79 deletion mutation were identified in proband 3. Conclusions Compound heterozygous mutations T2255G and C2671T of αⅡb gene lead to type Ⅰ Glanzmann thrombasthenia for proband 1. Homozygous mutation A2334C of αⅡb gene leads to type Ⅱ Glanzmann thrombasthenia for proband 2. Compound heterozygous mutations C1750T and 69-79del αⅡb gene lead to type Ⅰ Glanzmann thrombasthenia for proband 3. T2255G,C1671T and 69-79del aye novel mutations for αⅡb gene.

More
广告
  • 浏览403
  • 下载120
中华检验医学杂志

中华检验医学杂志

2008年31卷1期

55-59页

ISTICPKUCSCDCA

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

扩展文献

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷